國家衛生研究院 NHRI:Item 3990099045/14271
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 914470      線上人數 : 1377
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/14271


    題名: Discovery of a biomarker signature that reveals a molecular mechanism underlying diabetic kidney disease via organ cross talk
    作者: Wu, IW;Tsai, TH;Lo, CJ;Chou, YJ;Yeh, CH;Cheng, ML;Lai, CC;Sytwu, HK;Tsai, TF
    貢獻者: National Institute of Infectious Diseases and Vaccinology;Institute of Molecular and Genomic Medicine
    摘要: Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease, and it creates tremendous medical care costs. Accurate prediction of DKD and its potential molecular implications remain incompletely understood. Here, we apply artificial intelligence (AI) algorithms to build up an interaction model that tackles the complex interconnections between diabetes and chronic kidney disease (CKD) and to identify a biomarker signature that predisposes high-risk type 2 diabetes patients to progression to DKD. The cohort in this study contains 618 subjects, and these can be split into training (557 subjects) and testing (61 subjects) cohorts. Their mean age was 63.8 ± 12.9 years, and they included 287 males (46.4%). The median estimated glomerular filtration rate was 83.0 mL/min/1.73 m2. Of the subjects, 338 (54.7%) were control subjects, 112 (18.1%) had type 2 diabetes, 73 (11.8%) had nondiabetic CKD, and 95 (15.4%) had DKD (Fig. 1A). The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Institutional Review Board of Chang Gung Medical Foundation (Institutional Review Board no. 201800802B0, 202000077B0A3, 201800273B0C602, and 202002535B0). Informed consent was obtained from all subjects involved in the study.
    日期: 2022-06-02
    關聯: Diabetes Care. 2022 Jun 2;45(6):e102-e104.
    Link to: http://dx.doi.org/10.2337/dc22-0145
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0149-5992&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000886431800001
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85131270593
    顯示於類別:[司徒惠康] 期刊論文
    [其他] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB35546525.pdf13900KbAdobe PDF205檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋